Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A purine derivative belonging to the class of hypoxanthines, with a chemical formula of C15H23N5O or C16H24N6O depending on source (likely due to tautomeric forms or reporting differences)[1][2][3]. It is a small molecule with potential biological activities, but its specific mechanism of action and clinical indications are not well-documented in available sources. The compound is structurally related to other purine-based molecules that have been investigated for their activity as kinase inhibitors, but there is no direct evidence from current literature that this specific compound has been developed as a therapeutic agent or has entered clinical trials[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-(cyclohexylmethoxy)-8-isopropyl-9h-purin-2-amine.